Associated Papers
Drug development advances in human genetics-based targets.
Zhang X et al.
Medcomm, 2024
New Loss-of-Function Mutations in PCSK9 Reduce Plasma LDL Cholesterol.
Meng FH et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2023
Proteomics and Lipidomics to unveil the contribution of PCSK9 beyond cholesterol lowering: a narrative review.
Gianazza E et al.
Frontiers in Cardiovascular Medicine, 2023
Select a paper to view details